General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK

European Journal of Contraception and Reproductive Health Care

Volumn 16, Issue 4, 2011, Pages 311-318

  Middleton, Annie J ^a   Naish, Jeannette ^b   Singer, Nicola ^c  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b London School of Medicine and Dentistry   (United Kingdom)

^c City and Hackney Teaching Primary Care Trust   (United Kingdom)

Author keywords

General practitioner; Levonorgestrel releasing intrauterine system (LNG IUS); Nulligravid; Nulliparous; Questionnaire

Indexed keywords

LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DRUG RELEASE; ECTOPIC PREGNANCY; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MULTIPLE CHOICE TEST; PELVIC INFLAMMATORY DISEASE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; RELIABILITY; RISK FACTOR; UNITED KINGDOM;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; GENERAL PRACTITIONERS; GRAVIDITY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; LONDON; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; YOUNG ADULT;

EID: 79960703982     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2011.580864     Document Type: Article

References (24)

1. Department of Health. A bortion statistics, E ngland and Wales : 2009 . Statistical Bulletin September 2008. London: DH 2009. Accessed 25 October 2010 from: http:// www.dh.gov.uk
2. National Institute of Clinical Excellence (NICE). CG 30 Long-acting reversible contraception, Full Guideline; October 2005. Accessed 25 October 2010 from: http:// www.nice.org.uk/index.jsp
3. Kost K, Singh S, Vaughan B, et al. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 2008;77:10-21.
4. Lader D. Omnibus Survey Report Number 41. Contraception and sexual health September 2008. London: Offi ce of National Statistics 2009. Accessed 25 October 2010 from:
5. Haimovich S. Profi le of long-acting reversible contraception users in Europe. Eur J Contracept Reprod Health Care 2009;14:187-95.
6. Rö mer T, Linsberger D. User satisfaction with a levonorgestrel- releasing intrauterine system (LNG-IUS): Data from an international survey. Eur J Contracept Reprod Health Care 2009;14:391-8.
7. Prager S, Darney PD. The levonorgestrel intrauterine system in nulliparous women. Contraception 2007;75: S12 - 5 .
8. Brockmeyer A, Kishen M, Webb A. Experience of IUD/ IUS insertions and clinical performance in nulliparous women - A pilot study. Eur J Contracept Reprod Health Care 2008;13:248-54.
9. Fleming Fleming KL, Sokoloff A, Raine TR. Attitudes and beliefs about the intrauterine device among teenagers and young women. Contraception 2010; 82:178-82.
10. The City & Hackney Joint Strategic Needs Assessment 2009. Accessed 26 March 2011 from: http://www. hscf.org.uk/index.php?page- 52
11. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2008/2009). Accessed 10 November 2010 from:
12. Sivin I, Bat á r I. State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices. Eur J Contracept Reprod Health Care 2010;15:96-112.
13. Hubacher D, Lara-Ricalde R, Taylor DJ, e t al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345: 561-7. (Pubitemid 32772097)
14. Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: A meta-analysis of case-control studies. Contraception 1995;52:23-34.
15. Farmer M, Webb A. Intrauterine device insertion-related complications: Can they be predicted? J Fam Plann Reprod Health Care 2003;29:227-31. (Pubitemid 37271177)
16. Marions L, Lö vkvist L, Taube A, e t al. Use of the levonorgestrel releasing-intrauterine system in nulliparous women - a non-interventional study in Sweden. Eur J Contracept Reprod Health Care 2011;16:126-34.
17. Hubacher D, Reyes V, Lillo S, e t al. Pain from copper intrauterine device insertion: Randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006;195: 1272-7. (Pubitemid 44635393)
18. Veldhuis HM, Vos AG, Lagro-Janssen AL. Complications of the intrauterine device in nulliparous and parous women. Eur J General Practice 2004;10:82-7. (Pubitemid 39307183)
19. Lete I, Morales P, de Pablo JL. Use of intrauterine contraceptive devices in nulliparous women: Personal experience over a 12-year period. Eur J Contracept Reprod Health Care 1998;3:190-3. (Pubitemid 128690546)
20. Suhonen S, Haukkamaa M, Jakobsson T, e t al. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study. Contraception 2004;69: 407-12. (Pubitemid 38510332)
21. Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 1999;181: 1263-9.
22. Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: Biological bases of their mechanism of action. Contraception 2007;75:S16 - 30. (Pubitemid 46770712)
23. Gupta S, Miller JE. A survey of GP views in intrauterine contraception. Br J Fam Plann 2000;26:81-4.
24. Wellings K, Zhihong Z, Krentel A, et al. Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Contraception 2007;76: 208-14. (Pubitemid 47247663)